Presence of Toxins from Smoking in the Follicular Fluid of Women Undergoing Intracytoplasmic Sperm Injection Treatment
1 other identifier
observational
320
1 country
1
Brief Summary
Smoking is associated with many adverse health effects like circulatory disorders, pulmonary diseases or heart diseases. It was also shown that smoking correlates with a significantly higher risk for miscarriage, preterm birth or a significantly decreased implantation rate or life birth rate, thus affects the chance to have children. Combustion of tobacco products results in more than 4.000 toxic and/or carcinogenic substances. Examples of such substances are the carcinogenic substance Benzo(a)pyrene or nicotine and its main degradation product cotinine. Although the adverse effects of these substances were analyzed in many biological systems (e.g. cell culture, mouse model systems), less is known about the bio-accumulation in human tissue, especially in ovarian tissue or the follicular fluid (FF). The aim of this study is therefore to analyze the bio-accumulation of nicotine, cotinine and Benzo(a)pyrene in the follicular fluid of women with the unfulfilled desire to have children undergoing an intracytoplasmic sperm injection (ICSI) treatment. The analysis will be performed using a sensitive gas chromatography-mass spectroscopy (GC) in a control group (non-smoker) and a study group (smoker). For each group, a correlation analysis between the amount of toxic and/or carcinogenic substances and the clinical outcome (e.g. clinical pregnancy rate, fertilization rate) will be performed. In combination with a patient questionnaire, it will be possible to analyze the risk of smoking, the bio-accumulation of toxic substances in the follicular fluid, and the chance to have children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2018
CompletedFirst Posted
Study publicly available on registry
January 30, 2018
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2024
CompletedNovember 4, 2024
October 1, 2024
5.8 years
January 23, 2018
October 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy rate
Presence of amniotic cavity and heartbeat after embryo transfer
28 days after ICSI treatment
Study Arms (2)
Control Group
Non-smoker
Study Group
Smoker
Eligibility Criteria
female patients seeking ICSI treatment because of male subfertility
You may qualify if:
- \- healthy females without sterility factors
You may not qualify if:
- Endometriosis
- Polycystic ovary syndrome (PCO)
- Neoplasia (ovary, Uterus, breast)
- Anti-Müllerian hormone (AMH) \<1 ng/ml
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Infertility Treatment Center Dortmundlead
- TU Dortmund Universitycollaborator
- Ferring Pharmaceuticalscollaborator
Study Sites (1)
Infertility treatment center Dortmund
Dortmund, North Rhine-Westphalia, 44135, Germany
Related Publications (1)
Trapphoff T, Ontrup C, Krug S, Dieterle S. Consumption of hookahs, e-cigarettes, and classic cigarettes and the impact on medically assisted reproduction treatment. Sci Rep. 2024 Apr 26;14(1):9597. doi: 10.1038/s41598-024-60251-y.
PMID: 38671174DERIVED
Related Links
Biospecimen
Follicular fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Dieterle, MD
Infertility Treatment Center Dortmund
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2018
First Posted
January 30, 2018
Study Start
March 1, 2018
Primary Completion
December 30, 2023
Study Completion
May 28, 2024
Last Updated
November 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share